MILFORD, Mass.--(BUSINESS WIRE)--Jul. 9, 2014--
Waters Corporation (NYSE: WAT) today announced an agreement with the
Chinese Pharmacopoeia Commission (ChP) to establish a Joint Open
Laboratory. Scheduled to open before the end of 2014, the new Joint Open
Laboratory will focus on in-depth research of pharmacopoeia standards,
development of testing methods, methods validations and basic and
advanced technical training of pharmacopoeia detection methods. Both the
ChP and Waters® expect the laboratory to become one of the
national technical support centers in the field of Chinese
pharmaceutical standards.
"Waters is very excited about our new collaboration with the Chinese
Pharmacopeia Commission," said Art Caputo, President of the Waters
Division. "I am confident that this new Joint Open Laboratory will make
positive contributions to assuring drug quality control in China, it
will quickly become an international leader in the field of traditional
Chinese pharmaceutical standards."
At the collaboration agreement signing ceremony in Beijing, Secretary
General Zhang Wei of the ChP pointed out that "the ChP-Waters Joint Open
Laboratory cooperation would become another milestone of the development
of the ChP. This cooperation not only meets the needs of ChP’s own
development, but also meets the demands of enhanced pharmacopoeia
standards and improved public drug safety."
Located in the laboratory building of Beijing Zhendong Guangming Drug
Research Institute, the new Joint Open Laboratory is more than 400
square meters (more than 1300 square feet). The laboratory will be
outfitted with a full complement of Waters chromatography and mass
spectrometry technologies, including (but not limited to) a range of
ACQUITY UPLC® systems, ACQUITY UPC2® System, Xevo®
tandem quadrupole and time-of-flight mass spectrometers, and a Natural
Products Application Solution with UNIFI®.
About Chinese Pharmacopeia Commission
Commonly referred to as ChP, the Chinese Pharmacopeia Commission is an
official and authoritative compendium of drugs and has been in place
since 1950 – publishing compendiums in 1953, 1963, 1977, 1985, 1990,
1995, 2000, 2005, and 2010. Formerly reporting under the Chinese
Ministry of Health, it is now is an affiliated commission of the newly
formed Chinese Food and Drug Administration (CFDA). The Chinese
Pharmacopeia Commission is also officially recognized by the World
Health Organization.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation has created business
advantages for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant advancements
in such areas as healthcare delivery, environmental management, food
safety, and water quality, consumer products and high-value added
chemicals worldwide.
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring
platform for customer success.
With revenue of $1.9 billion in 2013, Waters is driving scientific
discovery and operational excellence for customers worldwide.
Waters, Xevo, UPLC, UPC2, ACQUITY, UNIFI, and ACQUITY UPLC
are trademarks of Waters Corporation.
Source: Waters Corporation
Waters Corporation
Jeff Tarmy, 508-482-2268
jeff_tarmy@waters.com